Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
18 April 2017 |
Main ID: |
ChiCTR-IPR-15006267 |
Date of registration:
|
2015-04-10 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Effect of propofol on insuline resistance in patients after operation
|
Scientific title:
|
Effect of propofol on insuline resistance in patients after operation |
Date of first enrolment:
|
2015-04-17 |
Target sample size:
|
sevoflurane group :80;sevo+propofol group :80;seoflurane+lipid carrier group :80; |
Recruitment status: |
Recruiting |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=10796 |
Study type:
|
Interventional study |
Study design:
|
Randomized parallel controlled trial
|
Phase:
|
I (Phase I study)
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Yaqun Ma
|
Address:
|
5 Haiyuncang, Dongcheng District, Beijing
|
Telephone:
|
+86 10 84008122 |
Email:
|
lyzgao@gmail.com |
Affiliation:
|
|
|
Name:
|
Yonzhe Liu
|
Address:
|
5 Haiyuncang, Dongcheng District, Beijing
|
Telephone:
|
+86 10 84008122 |
Email:
|
lyzgao@163.com |
Affiliation:
|
Beijing ilitary eneral ospital |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: ASAI-II,age from 50-75, years old and able to eat normally after sugery in patients.
Exclusion criteria: Exclusion criteria included a history of liver and kidney dysfunction and diabetes, interventions or drugs to insulin resistance and insulin secretion.
Age minimum:
50
Age maximum:
75
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
diabetes
|
Intervention(s)
|
sevoflurane group :sevoflurane anesthesia ;sevo+propofol group :sevoflurane+propofol ;seoflurane+lipid carrier group :sevoflurane+lipid carrier ;
|
Primary Outcome(s)
|
free fat acid;Glucose;Diacylglycerol;insulin;TNF;GLUT4;IRS-1;inhibitor of kB kinase;
|
Source(s) of Monetary Support
|
Department of anesthesiology, Beijing Military General Hospital
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|